日本新薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4516/E00931 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2014/05/30 | 日証協 | 235,731株 | +23.18% | 77,032株 | -21.28% | 270,262株 | +9.93% | 76,073株 | +209.53% |
2014/05/23 | 日証協 | 191,368株 | -10.42% | 97,853株 | +167.67% | 245,839株 | -8.37% | 24,577株 | -56.11% |
2014/05/16 | 日証協 | 213,620株 | +4.4% | 36,558株 | +52.05% | 268,281株 | +12.33% | 56,000株 | +143.48% |
2014/05/09 | 日証協 | 204,620株 | -1.44% | 24,043株 | -73.75% | 238,839株 | -3.24% | 23,000株 | +64.29% |
2014/05/02 | 日証協 | 207,620株 | -6.91% | 91,577株 | +90.61% | 246,839株 | -2.15% | 14,000株 | -30% |
2014/04/25 | 日証協 | 223,043株 | +5.69% | 48,043株 | -47.32% | 252,262株 | -1.56% | 20,000株 | -41.9% |
2014/04/18 | 日証協 | 211,043株 | +11.17% | 91,200株 | -16.18% | 256,262株 | -8.75% | 34,423株 | -75.76% |
2014/04/11 | 日証協 | 189,832株 | -5.95% | 108,800株 | +1108.89% | 280,839株 | -3.77% | 142,000株 | +105.73% |
2014/04/04 | 日証協 | 201,832株 | +36.01% | 9,000株 | -91.04% | 291,839株 | +67.9% | 69,022株 | +35.33% |
2014/03/28 | 日証協 | 148,390株 | +29.88% | 100,418株 | +4920.9% | 173,816株 | +10.87% | 51,001株 | +264.29% |
2014/03/20 | 日証協 | 114,248株 | -3.38% | 2,000株 | -97.42% | 156,768株 | -3.69% | 14,000株 | -53.22% |
2014/03/14 | 日証協 | 118,248株 | -4.88% | 77,647株 | +1.21% | 162,768株 | +12.38% | 29,929株 | +3.2% |
2014/03/07 | 日証協 | 124,319株 | -4.19% | 76,718株 | +1178.63% | 144,839株 | -4.25% | 29,000株 | +141.67% |
2014/02/28 | 日証協 | 129,752株 | -12.09% | 6,000株 | -45.45% | 151,272株 | -14.59% | 12,000株 | -62.83% |
2014/02/21 | 日証協 | 147,601株 | +1.85% | 11,000株 | -87.19% | 177,121株 | -10.62% | 32,282株 | +109.05% |
2014/02/14 | 日証協 | 144,927株 | +4.99% | 85,884株 | +81.67% | 198,165株 | -2.99% | 15,442株 | +10.3% |
2014/02/07 | 日証協 | 138,043株 | -34.76% | 47,275株 | +145.18% | 204,281株 | -2.7% | 14,000株 | +6.87% |
2014/01/31 | 日証協 | 211,601株 | -0.72% | 19,282株 | -73.11% | 209,939株 | +7.25% | 13,100株 | -62.89% |
2014/01/24 | 日証協 | 213,146株 | -30.28% | 71,718株 | -44.17% | 195,739株 | -26.06% | 35,300株 | +58.97% |
※株式分割は考慮していませんのでご注意ください。
Page Top